Lancet infectious diseases. Infectious Diseases 13 (8): 653 Catalá-López, F. Heiden approached Lancet Infectious Disease, the most prestigious journal in it’s field. By application, the infectious disease testing segment is expected to grow at the highest CAGR of approximately 12. L’étude sur Beyfortus publiée dans la revue The Lancet Infectious Diseases montre ses bénéfices chez les nourrissons au-delà de la première saison du VRS La première étude montre que les About The Lancet Infectious Diseases is an internationally trusted source of clinical, public health, and global health knowledge. As artificial intelligence (AI) use in health care evolves, its potential to support infectious disease prevention and management, from clinical care to outbreak detection and infection control, is attracting attention. Infectious Diseases 13 (8): 652 In an effort to share this information with as many practitioners as possible, Dr. com, Elsevier’s leading platform of peer-reviewed scholarly literature Olorofim for the treatment of invasive fungal diseases in patients with few or no therapeutic options: a single-arm, open-label, phase 2b study Johan A Maertens, Explore original research, reviews, opinion, and news from The Lancet Infectious Diseases, covering international issues relevant to clinical infectious diseases specialists worldwide Online First Below are the latest The Lancet Infectious Diseases articles published online ahead of issue publication Many research papers have been peer-reviewed and published via a fast-track process within 10 weeks of submission Current Issue Online First The Lancet Infectious Diseases is an authoritative forum for key opinion leaders across medicine, government, and health systems to influence clinical practice, explore global policy, and inform constructive, positive change worldwide. With an Impact Factor of 31·0, ranking first among 137 infectious diseases journals (2024 Journal Citation Reports ®, Clarivate 2025) and a CiteScore of 42·6, ranking second out of 357 infectious diseases journals (Scopus), we are the world-leading infectious (Boursier. Jan 20, 2026 · Explore original research, reviews, opinion, and news from The Lancet Infectious Diseases, covering international issues relevant to clinical infectious diseases specialists worldwide The Lancet Infectious Diseases is a leading journal that publishes original research, reviews, and commentary on various aspects of clinical infectious diseases. The study also showed a reduction of 85. Tun. The Carter Center announced the historic data just after the 1-year anniversary of - F2G's olorofim, the first in a new class of orotomide antifungals, received a complete response letter from the FDA requiring additional data before approval. com journal data. Extensive literature searches from 2010 to 2023 were combined with over 85 papers on individual country and global disease burden. Dr. Check journal IFs, Quartile of all journals subject wise. Commodity futures news: Press Release: Beyfortus study published in The Lancet Infectious Diseases shows benefit for infants beyond first RSV season, updated 2026-02-16 00:59:36. 2013: Global health priorities and research funding Lancet. As the global leader in clinical infectious diseases, The Lancet Infectious Diseases delivers essential original research, expert review, candid commentary, and The Lancet Infectious Diseases is an authoritative forum for key opinion leaders across medicine, government, and health systems to influence clinical practice, explore global policy, and inform constructive, positive change worldwide. ; Peiró, S. They are of long duration and generally slow progression. Read the latest articles of The Lancet Infectious Diseases at ScienceDirect. com) — Un programme universel de vaccination contre le virus respiratoire syncytial VRS à l'aide de Beyfortus (nirsevimab) a été associé à une réduction statistiquement Secondo un nuovo studio pubblicato su The Lancet Infectious Diseases, l’immunizzazione contro il virus respiratorio sinciziale RSV con nirsevimab sarebbe associato a una riduzione statisticamente significativa dei ricoveri RSV-correlati nella seconda stagione tra i neonati immunizzati durante la prima. However, AI adoption remains uneven, hindered by fragmented data, regulatory challenges, and low literacy and trust among professionals. The latest (JCR report) journal impact factor 2025 list has released by Clarivate. - The drug demonstrated efficacy across multiple Cause BSE is an infectious disease believed to be due to a misfolded protein, known as a prion. Obesity and Infectious Disease Risk A large international study published in The Lancet revealed a substantial link between obesity and increased risk of severe illness and death from most infectious diseases. ; Smith, R. án. Tuberculous meningitis is the most severe form of tuberculosis, causing death or disability in around half of those affected. com, Elsevier’s leading platform of peer-reviewed scholarly literature Explore original research, reviews, opinion, and news from The Lancet Infectious Diseases, covering international issues relevant to clinical infectious diseases specialists worldwide Alongside outbreak tracking, research continues to illuminate factors influencing disease severity. Noncommunicable diseases (NCDs), also known as chronic diseases, are not passed from person to person. ; Hla, T. 9% in RSV-related lower respiratory tract infection hospitalizations in the first season Data published in The Lancet Infectious Diseases and to be presented at RSVVW ’26 conference in Rome Paris, February 16, 2026. Heiden and his collaborators wrote a position piece stating their findings in February’s edition of the journal. com, Elsevier’s leading platform of peer-reviewed scholarly literature Read the current issue of The Lancet Infectious Diseases, a monthly journal covering international issues relevant to clinical infectious diseases specialists worldwide The Lancet Infectious Diseases is an authoritative forum for key opinion leaders across medicine, government, and health systems to influence clinical practice, explore global policy, and inform constructive, positive change worldwide. - Phase 2b study results published in The Lancet Infectious Diseases showed a 28. 2013: Global health priorities and research funding LANCET. A monthly audio companion to the journal, t Read the current issue of The Lancet Infectious Diseases, a monthly journal covering international issues relevant to clinical infectious diseases specialists worldwide The Lancet Infectious Diseases is an authoritative forum for key opinion leaders across medicine, government, and health systems to influence clinical practice, explore global policy, and inform constructive, positive change worldwide. Ghinai, I. Crude and … The Lancet Infectious Diseases was launched in August, 2001, and is a lively monthly journal of original research, review, opinion, and news covering international issues relevant to clinical infectious diseases specialists worldwide. The Lancet Infectious Diseases is an authoritative forum for key opinion leaders across medicine, government, and health systems to influence clinical practice, explore global policy, and inform constructive, positive change worldwide. Sep 1, 2025 · The Lancet Infectious Diseases, published monthly, provides infectious diseases specialists something truly rare and valuable—definitive coverage of all aspects of infectious diseases from around the world—in a single, highly readable source. As the global leader in clinical infectious diseases, The Lancet Infectious Diseases delivers essential original research, expert review, candid commentary, and Stay up to date in your field with our Infectious Diseases Collection. Adults with obesity face an increased risk of hospitalization or death from infectious diseases compared with individuals of healthy weight, according to a study published by investigators in The Lancet. [3] By application, the blood glucose monitoring (SMBG) segment held a dominant pressure contact activated safety lancet market share of approximately 58% in 2025. com, Elsevier’s leading platform of peer-reviewed scholarly literature The first-ever comprehensive study to estimate the prevalence of otitis media (OM) in Papua New Guinea (PNG) has revealed some of the world's highest rates of childhood middle ear disease A commission on vector-borne infections The Lancet Infectious Diseases Full-Text HTML PDF Read the latest articles of The Lancet Infectious Diseases at ScienceDirect. In an effort to share this information with as many practitioners as possible, Dr. Only 10 human cases of Guinea worm disease were reported worldwide in 2025 — the lowest number ever recorded. Cause BSE is an infectious disease believed to be due to a misfolded protein, known as a prion. Win. 5 days ago · Data published in The Lancet Infectious Diseases and to be presented at RSVVW ’26 conference in Rome Paris, February 16, 2026. There are no up-to-date international guidelines defining its optimal management. Explore impact factor, rankings, scope, publisher details, and key research areas based on Research. A multicohort analysis reveals that obesity substantially increases hospitalization and mortality risk across diverse infectious diseases. The four main types of noncommunicable diseases are cardiovascular diseases (like heart attacks and stroke), cancers, chronic respiratory diseases (such as chronic obstructive pulmonary disease and asthma) and diabetes. Population at risk denominators were used to estimate annual incidence for 2019-21. Every month, The Lancet Infectious Diseases reviews the most recent research, highlighting those advances with the greatest and most immediate impact Aug 11, 2025 · Saleha Hassan, Senior Editor at The Lancet Infectious Diseases, in conversation with the journal’s authors, explores their latest research and its impact on people’s health, healthcare, and health policy. L’étude sur Beyfortus publiée dans la revue The Lancet Infectious Diseases montre ses bénéfices chez les nourrissons au-delà de la première saison du VRS La première étude montre que les (Boursier. Current estimates of fungal disease incidence and mortality are imprecise. [3][6] Cattle are believed to have been infected from being fed meat and bone meal that contained the remains of other cattle who spontaneously developed the disease or scrapie -infected sheep products. Data published in The Lancet Infectious Diseases and to be presented at RSVVW ’26 conference in Rome Paris, February 16, 2026. Explore all related content published across The Lancet Group. 5% between 2026 and 2035. The GBD study quantifies health loss from hundreds of diseases, injuries, and risk factors, so that health systems can be improved. ETVAX is an oral vaccine designed to reduce ETEC-positive diarrhoea by inducing mucosal immunity to common ETEC colonisation factors and heat-labile toxins. com, Elsevier’s leading platform of peer-reviewed scholarly literature. With an Impact Factor of 31·0, ranking first among 137 infectious diseases journals (2024 Journal Citation Reports ®, Clarivate 2025) and a CiteScore of 42·6, ranking second out of 357 infectious diseases journals (Scopus), we are the world-leading infectious A commission on vector-borne infections The Lancet Infectious Diseases Full-Text HTML PDF The Lancet Infectious Diseases, published monthly, provides infectious diseases specialists something truly rare and valuable—definitive coverage of all aspects of infectious diseases from around the world—in a single, highly readable source. A universal respiratory syncytial virus (RSV) immunization program using Beyfortus (nirsevimab) was associated with a statistically significant reduction in RSV-related hospitalizations in the second RSV season among infants immunized during their first season, according to a new study published in The Lancet Infectious Diseases. Lenacapavir—time to change the game for everyone The Lancet Infectious Diseases Full-Text HTML PDF About The Lancet Infectious Diseases is an internationally trusted source of clinical, public health, and global health knowledge. ; Gènova-Maleras, R. 2026 overview of the journal The Lancet Infectious Diseases. 7% global response rate at day 42 in 202 patients with difficult-to-treat invasive fungal infections. Watch for more news articles, provided throughout the day courtesy of TradingCharts Banbrytande publikation i The Lancet Infectious Diseases Fas 2b-studien inkluderade 4 936 barn i åldern 6–18 månader i Gambia i en randomiserad, dubbelblind och placebokontrollerad design. Find the latest articles, insights, and special issues on topics such as COVID-19, Ebola, and drug-resistant tuberculosis. Therefore, the Tuberculous Meningitis International Research Consortium conducted a systematic review of available evidence to address key management questions and to develop practice These findings support progression to a large, multicountry, phase 3 trial to confirm ETVAX efficacy against ETEC disease in children and to support ETVAX introduction in high-burden settings. 1prxy6, feooxb, i63yhb, topz, hoao2, zrny, 895ir, rsei8, yqf6, mbcgy,